Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A potent, cost-effective RNase inhibitor

N R Murphy, S S Leinbach, R J Hellwig

    Biotechniques
    |June 1, 1995
    PubMed
    Summary

    A new potent protein-based PRIME Inhibitor offers superior performance for molecular biology applications compared to human placental RNase inhibitors (HPRI). This cost-effective solution enhances RNA-related experimental outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic variation across the human olfactory receptor repertoire alters odor perception.

    Proceedings of the National Academy of Sciences of the United States of America·2019
    Same author

    The ABCs of grant writing or "always be certain".

    Fund raising management·1999
    Same author

    Improved nucleic acid organic extraction through use of a unique gel barrier material.

    BioTechniques·1996
    Same author

    Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction.

    Virology·1994
    Same author

    Two-minute miniprep method for plasmid DNA isolation.

    BioTechniques·1994
    Same author

    Characterization of the single-stranded DNA-binding domain of the herpes simplex virus protein ICP8.

    Biochimica et biophysica acta·1989

    Area of Science:

    • Molecular Biology
    • Biochemistry
    • Enzymology

    Background:

    • Ribonucleases (RNases) degrade RNA, posing a challenge in molecular biology experiments.
    • Existing RNase inhibitors, such as human placental RNase inhibitors (HPRI), have limitations in stability and cost-effectiveness.

    Purpose of the Study:

    • To evaluate the performance characteristics of a novel protein-based RNase inhibitor, PRIME Inhibitor.
    • To assess the applicability of PRIME Inhibitor in various molecular biology techniques.

    Main Methods:

    • Characterization of PRIME Inhibitor's specific activity, temperature stability, and pH range.
    • Comparative analysis against commercial human placental RNase inhibitors (HPRI).
    • Testing PRIME Inhibitor's efficacy in key molecular biology applications.

    Main Results:

    • PRIME Inhibitor exhibits high specific activity and enhanced temperature stability.
    • It demonstrates a broad reaction pH range and superior cost-effectiveness compared to HPRI.
    • PRIME Inhibitor proved effective in in vitro transcription, translation, cDNA synthesis, RNA preparation, and RT-PCR.

    Conclusions:

    • PRIME Inhibitor is a potent and versatile RNase inhibitor.
    • Its unique protein nature and enhanced properties make it a superior alternative to HPRI.
    • PRIME Inhibitor offers a cost-effective solution for diverse RNA-based molecular biology workflows.

    Related Experiment Videos